Large trials confirm immunogenicity of H1N1 vaccines

Affiliations

Comment

Heath Kelly et al. Lancet. 2010.

. 2010 Jan 2;375(9708):6-9.

doi: 10.1016/S0140-6736(09)62132-2. Epub 2009 Dec 15.

¹ Epidemiology Unit, Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC 3051, Australia. heath.kelly@mh.org.au

No abstract available

Comment on

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.
Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, Li RC, Xia SL, Zhao YL, Li FJ, Yan SH, Yin WD, An K, Feng DJ, Cui XL, Qi FC, Ju CJ, Zhang YH, Guo ZJ, Chen PY, Chen Z, Yan KM, Wang Y. Liang XF, et al. Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15. Lancet. 2010. PMID: 20018364 Clinical Trial.
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.
Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Plennevaux E, et al. Lancet. 2010 Jan 2;375(9708):41-8. doi: 10.1016/S0140-6736(09)62026-2. Epub 2009 Dec 15. Lancet. 2010. PMID: 20018365 Clinical Trial.
Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
Vajo Z, Tamas F, Sinka L, Jankovics I. Vajo Z, et al. Lancet. 2010 Jan 2;375(9708):49-55. doi: 10.1016/S0140-6736(09)62039-0. Epub 2009 Dec 15. Lancet. 2010. PMID: 20018367 Clinical Trial.